Can aspirin (acetylsalicylic acid) cause prolonged prothrombin time (PT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: May 5, 2025 • View editorial policy

From the Guidelines

Aspirin can cause prolonged prothrombin time (PT) due to its effect on platelet function and the coagulation cascade. Aspirin inhibits platelet function by irreversibly blocking cyclooxygenase-1 (COX-1), which prevents the formation of thromboxane A2, a substance that promotes platelet aggregation 1. While aspirin's primary effect is on platelet function rather than clotting factors measured by PT, at higher doses or with prolonged use, it can affect the coagulation cascade enough to cause a modest increase in PT values.

Key Considerations

  • The effect of aspirin on PT is generally mild compared to anticoagulants like warfarin, which directly target clotting factors.
  • Patients taking aspirin who are undergoing surgery or procedures with bleeding risk should inform their healthcare providers about their aspirin use, as it may need to be temporarily discontinued 5-7 days before the procedure to allow platelet function to normalize.
  • Those with underlying bleeding disorders or taking other anticoagulants should be particularly cautious with aspirin use, as the combined effect could significantly increase bleeding risk and further prolong PT.
  • Recent guidelines suggest that the management of antiplatelet therapy, including aspirin, should be personalized based on the patient's risk of ischemic and bleeding events 2, 3.

Clinical Implications

  • Aspirin's effect on PT should be considered in the context of the patient's overall clinical profile, including their risk of bleeding and thrombotic events.
  • The decision to discontinue aspirin before a procedure should be made on a case-by-case basis, taking into account the patient's individual risk factors and the potential benefits and risks of aspirin therapy.
  • Clinicians should be aware of the potential interactions between aspirin and other medications, including anticoagulants and antiplatelet agents, and adjust treatment accordingly to minimize the risk of bleeding and thrombotic complications.

From the Research

Aspirin and Prolonged PT

  • Aspirin can affect coagulation by inhibiting platelet function and altering the formation of thrombi 4, 5.
  • High doses of aspirin can prolong the one-stage prothrombin time (PT) and increase whole blood fibrinolytic activity 5.
  • The serum thrombin time (STT) is prolonged in male subjects 2 hours and 24 hours after ingestion of aspirin, indicating that aspirin may alter endogenous thrombin activity 6.
  • Aspirin's antiplatelet action is due to inhibition of platelet cyclooxygenase (COX-1), which prevents thromboxane formation and results in an irreversible inhibition of platelet-dependent thromboxane formation 7.
  • However, aspirin does not decrease lipopolysaccharide (LPS)-induced coagulation, and its effect on PT is not consistently significant across different studies 8.

Mechanism of Aspirin's Effect on Coagulation

  • Aspirin inhibits platelet function by acetylating platelet cyclo-oxygenase, which prevents the access of the substrate to the catalytic site of the enzyme 4, 7.
  • Aspirin also inhibits the synthesis of PGI2 by vascular wall cells, but this effect is relatively short-lived and requires larger doses of aspirin 4.
  • The optimal antithrombotic dose of aspirin has not yet been determined, and its effect on coagulation can vary depending on the dose and individual response 4, 7.

Clinical Implications

  • Aspirin is effective in preventing arterial thromboses, but its use is associated with an increased risk of bleeding 4, 7.
  • The individual benefit/risk ratio determines the administration of aspirin, and its dosage requirements can differ in different organ circulations 7.
  • Aspirin's effect on coagulation should be considered when administering it to patients with bleeding disorders or those taking anticoagulant therapy 4, 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Effect of aspirin on hemostasis and thrombosis.

New England and regional allergy proceedings, 1986

Research

Effect of aspirin on serum thrombin time and bleeding time.

Prostaglandins, leukotrienes, and medicine, 1985

Related Questions

Does aspirin increase prothrombin time (PT)?
What is the mechanism of acetylsalicylic acid (Aspirin) elimination?
What is the mechanism of action of Acetylsalicylic acid (Aspirin) on platelet function?
Can aspirin (acetylsalicylic acid) cause bruising?
What is the recommended aspirin (acetylsalicylic acid) dosage for preventing blood clots during long-haul flights?
What are the rates of ventricular arrhythmias associated with isoproterenol (Isoprenaline)?
What is the significance of pericholecystic fluid on an ultrasound?
What are the signs of acute decompensation of liver cirrhosis?
What is the most likely predisposing factor for this patient's deterioration, characterized by hypoxemia, tachypnea, and new patchy opacification in the right lower lobe, after recent intubation in the Intensive Care Unit (ICU) and partial right nephrectomy, considering options including hospital admission greater than 48 hours, Chronic Obstructive Pulmonary Disease (COPD), upright position, recent intubation on Intensive Care Unit (ICU), and previous chest infection 6 weeks ago?
What is the most likely predisposing factor for this patient's deterioration, characterized by hypoxemia, tachypnea, and new patchy opacification in the right lower lobe, after recent intubation in the Intensive Care Unit (ICU) and partial right nephrectomy, considering options including hospital admission greater than 48 hours, Chronic Obstructive Pulmonary Disease (COPD), upright position, recent intubation on Intensive Care Unit (ICU), and previous chest infection 6 weeks ago?
What is the target range for Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT) before Percutaneous Coronary Intervention (PCI) procedure?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.